PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
150 hedge funds and large institutions have $311M invested in Progenics Pharmaceuticals Inc in 2018 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 48 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
37% less capital invested
Capital invested by funds: $491M → $311M (-$180M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
150
Holding in Top 10
–
Calls
$4.41M
Puts
$4.46M
Top Buyers
| 1 | +$20.1M | |
| 2 | +$2.47M | |
| 3 | +$2.43M | |
| 4 |
Millennium Management
New York
|
+$2.31M |
| 5 |
Citigroup
New York
|
+$1.96M |
Top Sellers
| 1 | -$19M | |
| 2 | -$12.5M | |
| 3 | -$8.02M | |
| 4 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$6.38M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.25M |